1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/38810
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRoss L.en
dc.contributor.authorBuchanan R.R.C.en
dc.contributor.authorDay J.en
dc.contributor.authorHoi A.Y.en
dc.date.accessioned2021-05-14T13:15:07Zen
dc.date.available2021-05-14T13:15:07Zen
dc.date.copyright2017en
dc.date.created20170311en
dc.date.issued2017-03-11en
dc.identifier.citationInternal Medicine Journal. 47 (3) (pp 250-256), 2017. Date of Publication: 01 Mar 2017.en
dc.identifier.issn1444-0903en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/38810en
dc.description.abstractAntiphospholipid syndrome is an autoimmune condition, characterised by the persistent presence of antiphospholipid antibodies and either thrombosis or obstetric morbidity. The cornerstone of therapy is long-term anticoagulation to reduce morbidity and mortality; however, better understanding of the immunological pathways may direct us to develop future therapeutic strategies. We provide an overview of the current understanding of the immunopathogenesis of this perplexing condition and its associated morbidities and current evidence for some of the immunotherapeutic strategies.Copyright © 2017 Royal Australasian College of Physiciansen
dc.languageEnglishen
dc.languageenen
dc.publisherBlackwell Publishing (E-mail: info@asia.blackpublishing.com.au)en
dc.relation.ispartofInternal Medicine Journalen
dc.titleImmunotherapeutic strategies in antiphospholipid syndrome.en
dc.typeReviewen
dc.type.studyortrialReview article (e.g. literature review, narrative review)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/imj.13245en
dc.publisher.placeAustraliaen
dc.identifier.pubmedid27572264 [http://www.ncbi.nlm.nih.gov/pubmed/?term=27572264]en
dc.identifier.source614679148en
dc.identifier.institution(Hoi, Ross, Day, Buchanan) Department of Rheumatology, Austin Health, Melbourne, VIC, Australia (Hoi) Department of Rheumatology, Monash Health, Melbourne, VIC, Australia (Hoi) School of Clinical Sciences, Monash University, Melbourne, VIC, Australiaen
dc.description.addressA.Y. Hoi, Department of Rheumatology, Austin Health, Melbourne, VIC, Australia. E-mail: alberta.hoi@austin.org.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2017 Elsevier B.V., All rights reserved.en
dc.subect.keywordsantiphospholipid syndrome CAPS therapeutic optionsen
dc.identifier.authoremailHoi A.Y.; alberta.hoi@austin.org.auen
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeReview-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Articles
Show simple item record

Page view(s)

30
checked on Oct 5, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.